Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II

Neurosurgery

Volumn 62, Issue 6, 2008, Pages 1314-1319

  Harris, Gordon J ^a   Plotkin, Scott R ^a   MacCollin, Mia ^a   Bhat, Shubha ^a   Urban, Trinity ^a   Lev, Michael H ^a   Slattery, William H ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOUSE EAR INSTITUTE   (United States)

Author keywords

Neurofibromatosis type II; Segmentation; Vestibular schwannoma; Volumetrics

Indexed keywords

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL NERVE TUMOR; FEMALE; GENETIC DISORDER; GROWTH RATE; HEARING IMPAIRMENT; HUMAN; LONGITUDINAL STUDY; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPONSE EVALUATION CRITERIA IN SOLID TUMOR; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; TUMOR GROWTH; TUMOR VOLUME; VOLUMETRY;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 56849109067     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000333303.79931.83     Document Type: Article

References (19)

1. Abaza MM, Makariou E, Armstrong M, Lalwani AK: Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope 106:694-699, 1996.
2. Baser ME, Makariou EV, Parry DM: Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2. J Neurosurg 96:217-222, 2002.
3. Charabi S, Thomsen J, Mantoni M, Charabi B, Jorgensen B, Borgesen SE, Gyldensted C, Tos M: Acoustic neuroma (vestibular schwannoma): Growth and surgical and nonsurgical consequences of the wait-and-see policy. Otolaryngol Head Neck Surg 113:5-14, 1995.
4. Chong VF, Zhou JY, Khoo JB, Huang J, Lim TK: Nasopharyngeal carcinoma tumor volume measurement. Radiology 231:914-921, 2004.
5. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R: Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought. Otol Neurotol 26:93-97, 2005.
6. Evans DG, Newton V, Neary W, Baser ME, Wallace A, Macleod R, Jenkins JP, Gillespie J, Ramsden RT: Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2). J Med Genet 37:944-947, 2000.
7. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57, 1997.
8. Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L: Vestibular schwannoma growth in patients with neurofibromatosis type 2: A longitudinal study. J Neurosurg 96:223-228, 2002.
9. Nakamura H, Jokura H, Takahashi K, Boku N, Akabane A, Yoshimoto T: Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma. AJNR Am J Neuroradiol 21:1540-1546, 2000.
10. Neff BA, Welling DB: Current concepts in the evaluation and treatment of neurofibromatosis type II. Otolaryngol Clin N Am 38:671-684, 2005.
11. Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE: CT Tumor measurement for therapeutic response assessment: Comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 225:416-419, 2002.
12. Rosenberg SI: Natural history of acoustic neuromas. Laryngoscope 110:497-508, 2000.
13. Slattery WH 3rd, Fisher LM, Iqbal Z, Oppenhiemer M: Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects. Otol Neurotol 25:811-817, 2004.
14. Slattery WH 3rd, Fisher LM, Yoon G, Sorensen G, Lev M: Magnetic resonance imaging scanner reliability for measuring changes in vestibular schwannoma size. Otol Neurotol 24:666-671, 2003.
15. Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, Yoon YH, Lee EJ, Yang MC, Lewis RF, Harris GJ, Lev M, Schaefer PW, Buchbinder BR, Barest G, Yamada K, Ponzo J, Kwon HY, Gennete J, Farkas J, Tievsky AL, Ziegler RB, Salhus MR, Weisskoff R: Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19:551-557, 2001.
16. Steiger JH: Test for comparing elements of a correlation matrix. Psychol Bull 87:245-251, 1980.
17. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000.
18. Vokurka EA, Herwadkar A, Thacker NA, Ramsden RT, Jackson A: Using Bayesian tissue classification to improve the accuracy of vestibular schwannoma volume and growth measurement. AJNR Am J Neuroradiol 23:459-467, 2002.
19. Yoshimoto Y: Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103:59-63, 2005.